Direct Recruitment of Polycomb Repressive Complex 1 to Chromatin by Core Binding Transcription Factors

Molecular Cell

Volumn 45, Issue 3, 2012, Pages 330-343

  Yu, Ming ^a,e   Mazor, Tali ^b,c,h   Huang, Hui ^a   Huang, Hsuan Ting ^a   Kathrein, Katie L ^a   Woo, Andrew J ^a   Chouinard, Candace R ^b,c   Labadorf, Adam ^b,c   Akie, Thomas E ^a   Moran, Tyler B ^a   Xie, Huafeng ^a   Zacharek, Sima ^a   Taniuchi, Ichiro ^d   Roeder, Robert G ^e   Kim, Carla F ^a,f   Zon, Leonard I ^a,f,g   Fraenkel, Ernest ^b,c   Cantor, Alan B ^a,f  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b Massachusetts Institute of Technology Cambridge   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d RIKEN   (Japan)

^e ROCKEFELLER UNIVERSITY   (United States)

^f HARVARD STEM CELL INSTITUTE   (United States)

^g HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BMI1 PROTEIN; CORE BINDING FACTOR BETA; POLYCOMB GROUP PROTEIN; POLYCOMB REPRESSIVE COMPLEX 1; POLYCOMB REPRESSIVE COMPLEX 2; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CHROMATIN; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IN VIVO STUDY; MEGAKARYOCYTE; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN DEPLETION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THYMOCYTE; ZEBRA FISH;

ANIMALS; CELL LINE; CHROMATIN; CHROMATOGRAPHY, AFFINITY; CLUSTER ANALYSIS; CORE BINDING FACTOR ALPHA 2 SUBUNIT; CORE BINDING FACTOR BETA SUBUNIT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HEMATOPOIETIC STEM CELLS; MEGAKARYOCYTES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; T-LYMPHOCYTES; THYMOCYTES; UBIQUITIN-PROTEIN LIGASES; ZEBRAFISH;

EID: 84863012512     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2011.11.032     Document Type: Article

References (50)

1. Appleford P.J., Woollard A. RUNX genes find a niche in stem cell biology. J. Cell. Biochem. 2009, 108:14-21.
2. Bakshi R., Hassan M.Q., Pratap J., Lian J.B., Montecino M.A., van Wijnen A.J., Stein J.L., Imbalzano A.N., Stein G.S. The human SWI/SNF complex associates with RUNX1 to control transcription of hematopoietic target genes. J. Cell. Physiol. 2010, 225:569-576.
3. Bejar R., Stevenson K., Abdel-Wahab O., Galili N., Nilsson B., Garcia-Manero G., Kantarjian H., Raza A., Levine R.L., Neuberg D., Ebert B.L. Clinical effect of point mutations in myelodysplastic syndromes. N.Engl. J. Med. 2011, 364:2496-2506.
4. Burns C.E., DeBlasio T., Zhou Y., Zhang J., Zon L., Nimer S.D. Isolation and characterization of runxa and runxb, zebrafish membersof the runt family of transcriptional regulators. Exp. Hematol. 2002, 30:1381-1389.
5. Burns C.E., Traver D., Mayhall E., Shepard J.L., Zon L.I. Hematopoietic stem cell fate is established by the Notch-Runx pathway. Genes Dev. 2005, 19:2331-2342.
6. Calés C., Román-Trufero M., Pavón L., Serrano I., Melgar T., Endoh M., Pérez C., Koseki H., Vidal M. Inactivation of the polycomb group protein Ring1B unveils an antiproliferative role in hematopoietic cell expansion and cooperation with tumorigenesis associated with Ink4a deletion. Mol. Cell. Biol. 2008, 28:1018-1028.
7. Chen M.J., Yokomizo T., Zeigler B.M., Dzierzak E., Speck N.A. Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter. Nature 2009, 457:887-891.
8. Dennis G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., Lempicki R.A. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003, 4:P3.
9. Drachman J.G., Sabath D.F., Fox N.E., Kaushansky K. Thrombopoietin signal transduction in purified murine megakaryocytes. Blood 1997, 89:483-492.
10. Elagib K.E., Racke F.K., Mogass M., Khetawat R., Delehanty L.L., Goldfarb A.N. RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation. Blood 2003, 101:4333-4341.
11. Eng J.K., McCormack A.L., Yates J.R. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J.Am. Soc. Mass Spectrom. 1994, 5:976-989.
12. Galli C., Fu Q., Wang W., Olsen B.R., Manolagas S.C., Jilka R.L., O'Brien C.A. Commitment to the osteoblast lineage is not required for RANKL gene expression. J.Biol. Chem. 2009, 284:12654-12662.
13. Georgiades P., Ogilvy S., Duval H., Licence D.R., Charnock-Jones D.S., Smith S.K., Print C.G. VavCre transgenic mice: a tool for mutagenesis in hematopoietic and endothelial lineages. Genesis 2002, 34:251-256.
14. Growney J.D., Shigematsu H., Li Z., Lee B.H., Adelsperger J., Rowan R., Curley D.P., Kutok J.L., Akashi K., Williams I.R., et al. Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood 2005, 106:494-504.
15. Guo Y., Papachristoudis G., Altshuler R.C., Gerber G.K., Jaakkola T.S., Gifford D.K., Mahony S. Discovering homotypic binding events at high spatial resolution. Bioinformatics 2010, 26:3028-3034.
16. Huang G., Zhang P., Hirai H., Elf S., Yan X., Chen Z., Koschmieder S., Okuno Y., Dayaram T., Growney J.D., et al. PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis. Nat. Genet. 2008, 40:51-60.
17. Huang H., Yu M., Akie T.E., Moran T.B., Woo A.J., Tu N., Waldon Z., Lin Y.Y., Steen H., Cantor A.B. Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. Mol. Cell. Biol. 2009, 29:4103-4115.
18. Ichikawa M., Asai T., Saito T., Seo S., Yamazaki I., Yamagata T., Mitani K., Chiba S., Ogawa S., Kurokawa M., Hirai H. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat. Med. 2004, 10:299-304.
19. Jacob B., Osato M., Yamashita N., Wang C.Q., Taniuchi I., Littman D.R., Asou N., Ito Y. Stem cell exhaustion due to Runx1 deficiency is prevented by Evi5 activation in leukemogenesis. Blood 2010, 115:1610-1620.
20. Kim W.Y., Sieweke M., Ogawa E., Wee H.J., Englmeier U., Graf T., Ito Y. Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains. EMBO J. 1999, 18:1609-1620.
21. Kissa K., Herbomel P. Blood stem cells emerge from aortic endothelium by a novel type of cell transition. Nature 2010, 464:112-115.
22. Lin H.F., Traver D., Zhu H., Dooley K., Paw B.H., Zon L.I., Handin R.I. Analysis of thrombocyte development in CD41-GFP transgenic zebrafish. Blood 2005, 106:3803-3810.
23. MacIsaac K.D., Lo K.A., Gordon W., Motola S., Mazor T., Fraenkel E. A quantitative model of transcriptional regulation reveals the influence of binding location on expression. PLoS Comput. Biol. 2010, 6:e1000773.
24. Margueron R., Reinberg D. The Polycomb complex PRC2 and its mark in life. Nature 2011, 469:343-349.
25. Miyazaki M., Miyazaki K., Itoi M., Katoh Y., Guo Y., Kanno R., Katoh-Fukui Y., Honda H., Amagai T., van Lohuizen M., et al. Thymocyte proliferation induced by pre-T cell receptor signaling is maintained through polycomb gene product Bmi-1-mediated Cdkn2a repression. Immunity 2008, 28:231-245.
26. Mohd-Sarip A., van der Knaap J.A., Wyman C., Kanaar R., Schedl P., Verrijzer C.P. Architecture of a polycomb nucleoprotein complex. Mol. Cell 2006, 24:91-100.
27. Motoda L., Osato M., Yamashita N., Jacob B., Chen L.Q., Yanagida M., Ida H., Wee H.J., Sun A.X., Taniuchi I., et al. Runx1 protects hematopoietic stem/progenitor cells from oncogenic insult. Stem Cells 2007, 25:2976-2986.
28. North T., Gu T.L., Stacy T., Wang Q., Howard L., Binder M., Marín-Padilla M., Speck N.A. Cbfa2 is required for the formation of intra-aortic hematopoietic clusters. Development 1999, 126:2563-2575.
29. Park I.K., Qian D., Kiel M., Becker M.W., Pihalja M., Weissman I.L., Morrison S.J., Clarke M.F. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 2003, 423:302-305.
30. Pasini D., Bracken A.P., Hansen J.B., Capillo M., Helin K. The polycomb group protein Suz12 is required for embryonic stem cell differentiation. Mol. Cell. Biol. 2007, 27:3769-3779.
31. Schoeftner S., Sengupta A.K., Kubicek S., Mechtler K., Spahn L., Koseki H., Jenuwein T., Wutz A. Recruitment of PRC1 function at the initiation of X inactivation independent of PRC2 and silencing. EMBO J. 2006, 25:3110-3122.
32. Setoguchi R., Tachibana M., Naoe Y., Muroi S., Akiyama K., Tezuka C., Okuda T., Taniuchi I. Repression of the transcription factor Th-POK by Runx complexes in cytotoxic Tcell development. Science 2008, 319:822-825.
33. Simon J.A., Kingston R.E. Mechanisms of polycomb gene silencing: knowns and unknowns. Nat. Rev. Mol. Cell Biol. 2009, 10:697-708.
34. Song W.J., Sullivan M.G., Legare R.D., Hutchings S., Tan X., Kufrin D., Ratajczak J., Resende I.C., Haworth C., Hock R., et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat. Genet. 1999, 23:166-175.
35. Speck N.A., Gilliland D.G. Core-binding factors in haematopoiesis and leukaemia. Nat. Rev. Cancer 2002, 2:502-513.
36. Sun W., Downing J.R. Haploinsufficiency of AML1 results in a decrease in the number of LTR-HSCs while simultaneously inducing an increase in more mature progenitors. Blood 2004, 104:3565-3572.
37. Talebian L., Li Z., Guo Y., Gaudet J., Speck M.E., Sugiyama D., Kaur P., Pear W.S., Maillard I., Speck N.A. T-lymphoid, megakaryocyte, and granulocyte development are sensitive to decreases in CBFbeta dosage. Blood 2007, 109:11-21.
38. van der Lugt N.M., Domen J., Linders K., van Roon M., Robanus-Maandag E., te Riele H., van der Valk M., Deschamps J., Sofroniew M., van Lohuizen M., et al. Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev. 1994, 8:757-769.
39. Villeval J.L., Cohen-Solal K., Tulliez M., Giraudier S., Guichard J., Burstein S.A., Cramer E.M., Vainchenker W., Wendling F. High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice. Blood 1997, 90:4369-4383.
40. Vincenz C., Kerppola T.K. Different polycomb group CBX family proteins associate with distinct regions of chromatin using nonhomologous protein sequences. Proc. Natl. Acad. Sci. USA 2008, 105:16572-16577.
41. Walrad P.B., Hang S., Joseph G.S., Salas J., Gergen J.P. Distinct contributions of conserved modules to Runt transcription factor activity. Mol. Biol. Cell 2010, 21:2315-2326.
42. Wang Q., Stacy T., Binder M., Marin-Padilla M., Sharpe A.H., Speck N.A. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl. Acad. Sci. USA 1996, 93:3444-3449.
43. Wang Q., Stacy T., Miller J.D., Lewis A.F., Gu T.L., Huang X., Bushweller J.H., Bories J.C., Alt F.W., Ryan G., et al. The CBFbeta subunit is essential for CBFalpha2 (AML1) function invivo. Cell 1996, 87:697-708.
44. Wilson B.G., Wang X., Shen X., McKenna E.S., Lemieux M.E., Cho Y.J., Koellhoffer E.C., Pomeroy S.L., Orkin S.H., Roberts C.W. Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation. Cancer Cell 2010, 18:316-328.
45. Wilson N.K., Foster S.D., Wang X., Knezevic K., Schütte J., Kaimakis P., Chilarska P.M., Kinston S., Ouwehand W.H., Dzierzak E., et al. Combinatorial transcriptional control in blood stem/progenitor cells: genome-wide analysis of ten major transcriptional regulators. Cell Stem Cell 2011, 7:532-544.
46. Woo C.J., Kharchenko P.V., Daheron L., Park P.J., Kingston R.E. A region of the human HOXD cluster that confers polycomb-group responsiveness. Cell 2010, 140:99-110.
47. Yu M., Wan M., Zhang J., Wu J., Khatri R., Chi T. Nucleoprotein structure of the CD4 locus: implications for the mechanisms underlying CD4 regulation during Tcell development. Proc. Natl. Acad. Sci. USA 2008, 105:3873-3878.
48. Yu M., Riva L., Xie H., Schindler Y., Moran T.B., Cheng Y., Yu D., Hardison R., Weiss M.J., Orkin S.H., et al. Insights into GATA-1-mediated gene activation versus repression via genome-wide chromatin occupancy analysis. Mol. Cell 2009, 36:682-695.
49. Zhang Y., Liu T., Meyer C.A., Eeckhoute J., Johnson D.S., Bernstein B.E., Nusbaum C., Myers R.M., Brown M., Li W., Liu X.S. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008, 9:R137.
50. Zhao J., Sun B.K., Erwin J.A., Song J.J., Lee J.T. Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science 2008, 322:750-756.